MarginProbe
Dilon Medical Technologies, Ltd. · Decision date Sep 17, 2025
What did the FDA approve?
FDA records P110014/S013 as a supplement to PMA P110014, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Sep 17, 2025.
FDA approval order statement
Approval for the modification of the MP 2.0 System including MP 2.0 Console and MP 2.a Probe with the use of multiple array technology with multiple sensors.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 17, 2025
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P110014/S013
- Regulatory pathway
- PMA supplement
- Applicant
- Dilon Medical Technologies, Ltd.
- Product code
- OEE
- Decision code
- APPR
- Decision date
- Sep 17, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Diagnostic low electric field.
- Applicant
- Dilon Medical Technologies, Ltd.
- Product code
- OEE
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P110014/S013 received
Application receipt date recorded by FDA.
P110014/S013 · FDA decision
Normal 180 Day Track
Timeline entries are records held by MedtechLedger for P110014. View FDA’s full supplement list.
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Dilon Medical Technologies, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 20 Alon Hatavor St., P.O. Box 3131, Business Park-South 3088900
Sources and methodology
- Original FDA record: P110014/S013
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records